<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="181728">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00728819</url>
  </required_header>
  <id_info>
    <org_study_id>807264</org_study_id>
    <nct_id>NCT00728819</nct_id>
  </id_info>
  <brief_title>Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters</brief_title>
  <official_title>Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two different marketed PICC (peripherally inserted
      central catheter) designs. Clotting rates, procedural bleeding and ease of catheter
      insertion will be compared. It is hypothesized that the non-tapered design has a lower
      clotting rate and is easier to place than the tapered design. Bleeding rates are expected to
      be about the same.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of PICC-related venous thrombosis</measure>
    <time_frame>28 days, PICC removal or hospital discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difficult/failed catheter placement</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative bleeding</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptomatic PICC-related venous thrombosis</measure>
    <time_frame>Procedure through 28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">340</enrollment>
  <condition>Venous Thrombosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tapered PICC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-tapered PICC</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tapered PICC</intervention_name>
    <description>Standard peripheral central catheter placement in the Brachial, Basilic or Cephalic veins</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-tapered PICC</intervention_name>
    <description>Standard peripheral central catheter placement in the Brachial, Basilic or Cephalic veins</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All inpatients, age 18 to 90, in need of de novo central venous access with a double
             lumen catheter indication of &gt; 2 weeks

          -  Informed consent and HIPAA consent forms discussed and signed by patient or their
             authorized representative

        Exclusion Criteria:

          -  Skin related problems around the insertion site (infection, phlebitis, scars)

          -  History of mastectomy/axillary dissection on insertion side

          -  Coagulopathy with an INR of &gt; 2.0

          -  Thrombocytopenia with platelets &lt; 25,000 uL

          -  Renal insufficiency with a creatinine of &gt; 3.0 mg/dL

          -  Documented current upper extremity or central venous thrombosis

          -  Hypercoagulable states (protein C or S deficiency, AT-III deficiency, lupus
             anticoagulant)

          -  Catheters needed for therapy within less than an hour (emergent placement not
             allowing sufficient time for proper research consent and randomization)

          -  Patient has already been enrolled in this research study

          -  Life expectancy less than 1 month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxim Itkin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <lastchanged_date>June 13, 2012</lastchanged_date>
  <firstreceived_date>July 31, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Inpatients</keyword>
  <keyword>Requiring</keyword>
  <keyword>DL PICC</keyword>
  <keyword>Access</keyword>
  <keyword>Medications</keyword>
  <keyword>Blood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
